Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus

Published:2010-06 Issue:6 Volume:59 Page:873-878
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Emoto Masanori,Mori Katsuhito,Lee Eiko,Kawano Naoya,Yamazaki Yuko,Tsuchikura Shoko,Morioka Tomoaki,Koyama Hidenori,Shoji Tetsuo,Inaba Masaaki,Nishizawa Yoshiki

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference30 articles.

1. Pathogenesis of vascular calcification in dialysis patients;Ketteler;Clin Exp Nephrol,2005

2. Fetuin-A and extraosseous calcification in uremia;Ketteler;Curr Opin Nephrol Hypertens,2005

3. The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis;Schinke;J Biol Chem,1996

4. The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification;Schafer;J Clin Invest,2003

5. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study;Ketteler;Lancet,2003

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Evidence Linking the Liver to the Cardiovascular System: Liver-derived Secretory Factors;Journal of Clinical and Translational Hepatology;2023-05-12

2. Crosstalk between the liver and kidney in diabetic nephropathy;European Journal of Pharmacology;2022-09

3. Role of Fetuin-A in the Pathogenesis of Psoriasis and Its Potential Clinical Applications;Clinical, Cosmetic and Investigational Dermatology;2022-04

4. Fetuin-A and risk of diabetes-related vascular complications: a prospective study;Cardiovascular Diabetology;2022-01-08

5. Serum level of fetuin-A in systemic lupus erythematosus patients: association with atherosclerosis and disease activity;Clinical Rheumatology;2021-01-07